Reduced Presence of SARS-CoV-2 microRNA-like Small RNA in the Serum of Patients with Post-Acute Sequelae SARS-CoV-2 Infection
Authors:
- Maria Alfreda StincarelliMSMaria Alfreda Stincarelli
- Isabella AbbateIsabella Abbate
- Giulia MatusaliGMGiulia Matusali
- Michele TanturliMTMichele Tanturli
- Marta CamiciMarta Camici
- Rosaria ArviaRARosaria Arvia
- Elisabetta LazzariELElisabetta Lazzari
- Eleonora CiminiECEleonora Cimini
- Alessandra VergoriAVAlessandra Vergori
- Fabrizio MaggiFMFabrizio Maggi
- Simone GiannecchiniSimone Giannecchini
Open Access
- 9 January 2025
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 13 (1) , 126
Abstract
The mechanisms underlying post-acute sequelae of SARS-CoV-2 infection (PASC) are a topic of debate. This study examined the presence of SARS-CoV-2 microRNA (miRNA)-like small RNAs in extracellular fluids and their potential link to PASC by using a quantitative stem-loop RT-PCR MiRNA assay. Initially, it was demonstrated that three previously identified SARS-CoV-2 miRNA-like small RNAs, specifically svRNA 1 and 2 and miR-07a, were significantly expressed in infected cells in vitro and released into the supernatant following infection by different SARS-CoV-2 variants. Then, the expression of three SARS-CoV-2 small RNAs was studied in both nasopharyngeal swabs (NPS) and sera from 24 patients at their initial COVID-19 diagnosis (T0) and in sera collected 91 to 193 days post-diagnosis (T1). Notably, 11 out of 24 patients (46%) reported PASC consequences. All NPS samples showed SARS-CoV-2 small RNA expression with an altered cytokine network during acute infection, but it did not correlate with PASC outcomes. Serum samples had similar small RNA statuses, though PASC patients, notably at T1, but not at T0, displayed reduced overall positivity compared to those without PASC. The host target expression of SARS-CoV-2 small RNAs was not significantly different between groups. This suggests a need for further research into SARS-CoV-2 small RNA and its role in viral behavior and PASC consequences.Keywords
Funding Information
- Fondazione “Istituto di Ricerca Virologica Oretta Bartolomei Corsi” Florence, Italy (2021, 00149)
- Italian Ministry of Health (2021, 00149)
This publication has 33 references indexed in Scilit:
- Regulatory role of miRNAs in the human immune and inflammatory response during the infection of SARS‐CoV‐2 and other respiratory viruses: A comprehensive reviewReviews in Medical Virology, 2024
- Viral and host small RNA transcriptome analysis of SARS-CoV-1 and SARS-CoV-2-infected human cells reveals novel viral short RNAsHeliyon, 2024
- Integrative role of small non-coding RNAs in viral immune response: a systematic reviewMolecular Biology Reports, 2024
- Intrinsic factors behind long COVID: III. Persistence of SARS‐CoV‐2 and its componentsJournal of Cellular Biochemistry, 2023
- SARS-CoV-2 produces a microRNA CoV2-miR-O8 in patients with COVID-19 infectioniScience, 2023
- Intrinsic factors behind long‐COVID: I. Prevalence of the extracellular vesiclesJournal of Cellular Biochemistry, 2023
- Extracellular vesicles engagement during respiratory viruses infectionAspects of Molecular Medicine, 2023
- Persistent circulation of soluble and extracellular vesicle‐linked Spike protein in individuals with postacute sequelae of COVID‐19Journal of Medical Virology, 2023
- Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort studyThe Lancet, 2022
- SARS-CoV-Encoded Small RNAs Contribute to Infection-Associated Lung PathologyCell Host & Microbe, 2017